GME's Q1 results are likely to reflect y/y EPS growth despite falling sales, but valuation and fundamentals raise questions.

Phase 2 trial results continue to show clinically meaningful efficacy and durable responses, including 36.5-month median overall survival after four years of follow-up, with a manageable safety profile Findings presented today at ASCO 2025 and concurrently published in The Lancet Oncology For U.S. media and investors only DUBLIN , June 2, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term data, including the first report of median overall survival (OS) from the Phase 2 trial evaluating Ziihera® (zanidatamab-hrii), a dual HER2-targeted bispecific antibody, in combination with chemotherapy for the investigational use in first-line HER2-positive (IHC 3+ or IHC …

Prosecutors aren't the only ones arguing for a smaller Google. Some critics say it might be better for investors, customers and innovation.

AVO eyes Q2 gains from strong avocado pricing, blueberry volume growth and global sourcing agility amid near-term cost pressures and tariff uncertainties.

PLNT navigates near-term challenges with strategic growth move. Here is what investors should watch.

LDOS stock is climbing on rising backlogs, improving earnings estimates, and a healthy solvency position.

Berkshire Hathaway B (BRK.B) reported earnings 30 days ago. What's next for the stock?

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=151290&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Canopy Growth Corporation (NASDAQ:CGC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/canopy-growth-corporation-lawsuit-submission-form?prid=151292&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Krispy Kreme, Inc. (“Krispy Kreme” or the “Company”) (NASDAQ: DNUT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=151296&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=151295&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

MARLBOROUGH, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- ConnectM Technology Solutions, Inc. (OTC: CNTM) (“ConnectM” or the “Company”), a high-growth technology company on the leading edge of the modern energy economy, today issued an update to its stockholders regarding the recent buyout offer by a group of longstanding stockholders.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=151289&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq.

Customers are Encouraged to Check Eligibility and Apply for Monthly Electric Discount OAKLAND, Calif. , June 2, 2025 /PRNewswire/ -- More than an estimated 150,000 additional Pacific Gas and Electric Company (PG&E) customers are now eligible for an 18% discount on their electric rate.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=151293&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Napco To Contact Him Directly To Discuss Their Options

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=151291&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit is pending against Rocket Companies, Inc. (“Rocket Companies” or the “Company”) (NYSE: RKT). Investors in Rocket Companies securities are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

WTS rides a 26% stock surge with strong M&A moves, new tech and margin gains despite weak Europe sales.